The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple-negative breast cancer
Ontology highlight
ABSTRACT: The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple-negative breast cancer
PROVIDER: PRJNA803306 | ENA |
REPOSITORIES: ENA
ACCESS DATA